Literature DB >> 21647645

Optimizing treatment strategies in paediatric atypical hemolytic uremic syndrome.

Aoife Waters.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21647645     DOI： 10.1007/s00467-011-1930-x

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  3 in total

1.  Efficacy of eculizumab in a patient with factor-H-associated atypical hemolytic uremic syndrome.

Authors:  Anne-Laure Lapeyraque; Véronique Frémeaux-Bacchi; Pierre Robitaille
Journal:  Pediatr Nephrol       Date:  2010-12-15       Impact factor: 3.714

Review 2.  aHUS caused by complement dysregulation: new therapies on the horizon.

Authors:  Aoife M Waters; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2010-06-18       Impact factor: 3.714

3.  Long-term renal function under plasma exchange in atypical hemolytic uremic syndrome.

Authors:  Jean-Claude Davin; Jaap Groothoff; Valentina Gracchi; Antonia Bouts
Journal:  Pediatr Nephrol       Date:  2011-06-07       Impact factor: 3.714
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.